 Source: JHVEPhoto Shutterstock.com Teva Pharmaceuticals NYSE: TEVA stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits. According to recent reports, Teva Pharmaceuticals is prepared to pay a proposed 4.35 billion to settle lawsuits connected to the opioid crisis in the U.S. That covers 3.7 billion in cash to local governments, 1.2 billion worth of opioid overdose treatment naloxone, as well as other payments. 